Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins. - Gong JN; Djajawi TM; Moujalled DM; Pomilio G; Khong T; Zhang LP; Fedele PL; Low MS; Anderson MA; Riffkin CD; White CA; Lan P; et al. (Cell death and differentiation, 2025)